Composition
- Active ingredients
- GRANISETRON HYDROCHLORIDE EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- GRANISETRON HYDROCHLORIDE EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- GRANISETRON HYDROCHLORIDE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA020239-002 · Discontinued
- GRANISETRON HYDROCHLORIDE EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA020239-003 · Discontinued
- GRANISETRON HYDROCHLORIDE EQ 3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA020239-001 · Discontinued
- GRANISETRON HYDROCHLORIDE EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** · TabletNDA020305-002 · Discontinued
- GRANISETRON HYDROCHLORIDE EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** · TabletNDA020305-001 · Discontinued
- GRANISETRON HYDROCHLORIDE EQ 2MG BASE/10ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution
At a glance
- Brand name
- Kytril
- Active substance
- granisetron hydrochloride
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Roche
- Status
- Discontinued
- FDA approval
- 29 Dec 1993
- Application
- NDA020239-004